Cancer immunotherapy mechanisms in action

Eventos
20/09/2022
Cancer immunotherapy mechanisms in action
Eventos
Unidad de comunicación
T +34 848 422 201
20/09/2022
Añadir al calendario 2022-09-20 09:30:00 2022-09-08 08:53:21 Cancer immunotherapy mechanisms in action SCIENTIFIC PROGRAM9.30 – 9:10 OpeningMaría Rodríguez, CUN. Ignacio Melero, CUN. Pamplona, Spain 9.10 -10.40 Chair:Ignacio Melero, CUN. Pamplona, Spain 9.10 – 9.40 Immunological mechanisms of resistance to CDK4/6 inhibitors in breast cancerLorenzo Galluzzi. Weil Cornell. NYC, USA 9.40 – 10.10 Combining immunotherapy and radiotherapyMaria Rodríguez Ruiz. CUN. Pamplona, Spain 10.10 – 10.40 Relevance of systemic inmunity to PDL1-PD1 blockade inmmunotherapyDavid Escors. Navarrabiomed. Pamplona, Spain 10.40-11.00 Q & A 11.00 – 11.30 Coffee break 11.30 - 12.30 Chair:María Rodríguez Ruiz, CUN. Pamplona, Spain 11.30 – 12.00 Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast CancerFernando Lecanda. CIMA. Pamplona, Spain 12.00 – 12.30 Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancerAitziber Buqué. Weil Cornell. NYC, USA 12.30 – 12-45 Q & A 12.45-13.45. How to get published in a high impact journal. Editor tipsLorenzo Galluzzi. Weil Cornell. NYC, USA 13.45-14.00 Q & A Event supported by CRUK, FCAECC and AIRC under the C18915/A29362 Accelerator Award Program INSCRIPCIONES en el email eguirado@unav.es  Event supported by           Salón de actos del CIMA https://cima.cun.es/ https://www.cun.es/ https://cima.cun.es/ https://www.cun.es/ Europe/Madrid public

SCIENTIFIC PROGRAM
9.30 – 9:10 Opening
María Rodríguez, CUN. Ignacio Melero, CUN. Pamplona, Spain

9.10 -10.40 Chair:
Ignacio Melero, CUN. Pamplona, Spain

9.10 – 9.40 Immunological mechanisms of resistance to CDK4/6 inhibitors in breast cancer
Lorenzo Galluzzi. Weil Cornell. NYC, USA

9.40 – 10.10 Combining immunotherapy and radiotherapy
Maria Rodríguez Ruiz. CUN. Pamplona, Spain

10.10 – 10.40 Relevance of systemic inmunity to PDL1-PD1 blockade inmmunotherapy
David Escors. Navarrabiomed. Pamplona, Spain

10.40-11.00 Q & A

11.00 – 11.30 Coffee break

11.30 - 12.30 Chair:
María Rodríguez Ruiz, CUN. Pamplona, Spain

11.30 – 12.00 Tumor ENPP1 (CD203a)/Haptoglobin Axis Exploits Myeloid-Derived Suppressor Cells to Promote Post-Radiotherapy Local Recurrence in Breast Cancer
Fernando Lecanda. CIMA. Pamplona, Spain

12.00 – 12.30 Immunoprophylactic and immunotherapeutic control of hormone receptor-positive breast cancer
Aitziber Buqué. Weil Cornell. NYC, USA

12.30 – 12-45 Q & A

12.45-13.45. How to get published in a high impact journal. Editor tips
Lorenzo Galluzzi. Weil Cornell. NYC, USA

13.45-14.00 Q & A

Event supported by
CRUK, FCAECC and AIRC under the C18915/A29362 Accelerator Award Program

INSCRIPCIONES en el email eguirado@unav.es 

Event supported by